Mid-term report 2016 – Cancer prevention and precision medicine

In connection with Stiftelsen Kristian Gerhard Jebsen's Mid-term evaluation of The K.G. Jebsen Colorectal Cancer Research Centre, we have issued a Mid-term report.

Mid-term report 2016

Link to the report Mid-term_report 2016_oppslag

Latest publications

Berg et al. 2019. Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains. Oncogene [Epub ahead of print] Sveen A, Kopetz S, Lothe RA. 2019. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat. Rev. Clin. Oncol. [Epub ahead of print] Marcuello et al. 2019. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol. Asp. Med. [Epub ahead of print] Smeby et al. 2019. Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer. Oncogenesis 8(6): 35 Kryeziu et al., 2019. Combination therapies with HSP90 inhibitors against colorectal cancer. BBA Reviews on Cancer, 1871(2): 240-247 All publications